The Singular Health (ASX:SHG) share price launched 27% higher today

The Singular Health Group Ltd (ASX: SHG) share price rocketed 27% higher today, but with no news out we cover the recent developments.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Singular Health Group Ltd (ASX: SHG) share price took flight today, increasing by 27.2% to 51.5 cents a share. However, the recently listed medical imaging technology company had no news out today.

Singular Health has gained a spot on plenty of watchlists over the last couple of weeks. It might be worth recapping what all the fuss is about.

Two children and a dog get set to launch their friend rocketing high into the sky.

Image source: Getty Images

What does Singular Health offer?

The proprietary technology developed by Singular Health enables the viewing of a 3D image, which is compiled of 2D medical images. More specifically, this technology is the company's volumetric rendering platform.

Singular Health notes that this technology provides immersive viewing across a range of medical applications. Such applications include orthodontics, maxilla-facial surgery, oncology, general surgery, and orthopedics.

In addition to this, MedVR is Singular Health's product which allows the viewing of scans through an interactive virtual reality experience.

The company derives its revenue from both initial hardware sales and subscription payments on an on-going basis for the use of software, commonly referred to a software-as-a-service (SaaS).

Recent Singular Health developments affecting the share price

With Singular Health being a small and upcoming player in a fairly competitive space, shareholders would be looking for progress. On Monday, shareholders got exactly that. The company announced that it had received a purchase order totalling $170,000 for development of GeoVR software.

The order was received from FlowCentric Technologies, with which Singular Health is also in the process of finalising a joint venture. The purchase order will enable FlowCentric to conduct a pilot program using Singular Health's GeoVR software.

You might be thinking, well this a world away from medical imaging. And you'd be correct. But the volumetric rendering technology developed by Singular Health spans multiple use cases. In this instance, it will be used to develop a commercially viable product that utilises imaging and predictive technologies for mining and exploration.

FlowCentric currently services over 350,000 users with its business process management software. These include a number of global resource companies.

For further progress on the medical imaging front, shareholders will have to wait a little longer to see that play out.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A woman in a red dress holding up a red graph.
Broker Notes

Macquarie names 3 ASX shares to buy

Two miners and a packaging company are on the broker's list of stocks to watch.

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another rough day for the markets this Wednesday.

Read more »

people looking through comical glasses, what to look for, reporting season, person thinking, person interested
Share Gainers

Are APA shares a buy after reaching a three-year high?

Can the share price keep storming higher in 2026?

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Broker Notes

Are these ASX shares a buy, hold or sell according to Morgans after key updates?

Here's the latest guidance from Morgans.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A service station attendant crosses his arms and smiles towards the camera with a backdrop of petrol bowsers and a drive-through facility.
Energy Shares

Ampol shares surge 50% to a two-year high: Buy, sell or hold?

Find out what upside analysts are tipping for Ampol shares next.

Read more »

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Broker Notes

Should you buy CBA shares for their 'consistent profitability'?

A leading analyst gives his outlook for CBA’s outperforming shares.

Read more »

An army soldier in combat uniform takes a phone call in the field.
Opinions

Forget DroneShield shares, I'd buy these ASX defence stocks instead

These ASX defence stocks look like they have a better upside than DroneShield shares over the next 12 months.

Read more »